Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2006. Start Trial.
Date Value
November 12, 2026 0.5536
November 11, 2026 0.5555
November 10, 2026 0.5574
November 09, 2026 0.5569
November 06, 2026 0.5507
November 05, 2026 0.5491
November 04, 2026 0.5811
November 03, 2026 0.5716
November 02, 2026 0.5754
October 30, 2026 0.5745
October 29, 2026 0.6041
October 28, 2026 0.6046
October 27, 2026 0.5669
October 26, 2026 0.5735
October 23, 2026 0.5593
October 22, 2026 0.5503
October 21, 2026 0.546
October 20, 2026 0.5446
October 19, 2026 0.5469
October 16, 2026 0.537
October 15, 2026 0.5488
October 14, 2026 0.5507
October 13, 2026 0.5493
October 12, 2026 0.5469
October 09, 2026 0.5707
Date Value
October 08, 2026 0.5688
October 07, 2026 0.5702
October 06, 2026 0.5726
October 05, 2026 0.5735
October 02, 2026 0.5858
October 01, 2026 0.6034
September 30, 2026 0.6167
September 29, 2026 0.6221
September 28, 2026 0.6273
September 25, 2026 0.6249
September 24, 2026 0.6358
September 23, 2026 0.6495
September 22, 2026 0.651
September 21, 2026 0.6382
September 18, 2026 0.6453
September 17, 2026 0.6567
September 16, 2026 0.6552
September 15, 2026 0.6595
September 14, 2026 0.6628
September 11, 2026 0.6533
September 10, 2026 0.6647
September 09, 2026 0.6813
September 08, 2026 0.6746
September 04, 2026 0.6453
September 03, 2026 0.6491

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
DBV Technologies SA 4.698
Akari Therapeutics Plc 0.6523
Cellectis SA 2.918
Alkermes Plc 4.237
Alnylam Pharmaceuticals, Inc. 6.130

Price to Book Value Related Metrics